Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on August 12, 2026

11 hours ago

NOTICE TO DISREGARD -- Leading Edge Health Inc

Indeterminate GlobeNewswire

11 hours ago

DM Injury Law Reaches $2.5 Million Settlement for Delivery Driver Injured in Illinois Crash

Indeterminate GlobeNewswire

12 hours ago

NurExone Announces Binding MOU with Made Scientific for U.S. GMP Manufacturing and Commercial Supply Partnership

Indeterminate GlobeNewswire

13 hours ago

Park Dental Partners Announces Second Quarter 2026 Results

Indeterminate GlobeNewswire

13 hours ago

Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

13 hours ago

AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

13 hours ago

First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

13 hours ago

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Indeterminate GlobeNewswire

13 hours ago

Range Impact Reports 2Q 2026 Financial Results

Indeterminate GlobeNewswire

13 hours ago

Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

Indeterminate GlobeNewswire

13 hours ago

Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

13 hours ago

Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

13 hours ago

Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

13 hours ago

Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

13 hours ago

Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Indeterminate GlobeNewswire

13 hours ago

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

Indeterminate GlobeNewswire

13 hours ago

MaxCyte Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

13 hours ago

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

Indeterminate GlobeNewswire

13 hours ago

BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results

Indeterminate GlobeNewswire

13 hours ago

BioStem Technologies Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire